近日，公司使用闲置自有资金进行现金管理的产品到期赎回并继续进行现金 管理，现就相关情况公告如下： 一、使用闲置自有资金进行现金管理到期赎回的基本情况 公司子公司江西中欣埃克盛新材料有限公司（以下简称"江西埃克盛"）与招 商银行股份有限公司绍兴分行营业部签订协议，使用闲置自有资金进行现金管理， 具体内容详见公司于 2025 年 10 月 10 日在巨潮资讯网（http://www.cninfo.com.cn） 上披露的《关于使用闲置自有资金进行现金管理到期赎回并继续进行现金管理的 公告》（公告编号：2025-074）。公司已赎回本金 6,000 万元并收到理财收益 335,638.36 元，具体情况如下： | 购买 | 受托方 | 产品 | 产品 | 金额 | 起息日 | 到期日 | 预计年化 | 实际收益 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 主体 | 名称 | 类型 | 名称 | （万元） | | | 收益率 | （元） | 证券代码：002915 证券简称：中欣氟材 公告编号：2026-005 浙江中欣氟材股份有限公司 关于 ...

Core Viewpoint - Zhejiang Zhongxin Fluorine Materials Co., Ltd. has received approval from the CSRC for a simplified procedure to issue shares to specific targets, raising a total of 186 million yuan for projects related to new materials and working capital [1] Group 1: Company Developments - The funds raised will be used for the construction of projects to produce 2000 tons of BPEF, 500 tons of BPF, and 1000 tons of 9-fluorenone, which are essential for the company's main business in the new materials sector [1] - The implementation of these projects is expected to enhance the company's core business advantages, expand product offerings, and strengthen its industry influence and profitability [1] Group 2: Industry Context - The new materials industry is a strategic and foundational sector that supports the modern industrial system and is crucial for developing new production capabilities and growth drivers [1] - The Chinese government has been actively promoting the development of the new materials industry through various supportive policies, leading to rapid growth and expansion of the market [1] Group 3: Market Opportunities - BPEF and BPF products are widely used in the synthesis of high polymer materials, with demand spanning high-growth sectors such as automotive, electronics, optical devices, smart home, aerospace, and defense [2] - The current market for BPEF shows a significant supply gap due to the limited number of domestic commercial production enterprises, providing a market opportunity for Zhongxin Fluorine Materials to expand production [2] Group 4: Strategic Insights - The production of 9-fluorenone as a core intermediate will effectively reduce the procurement costs and supply risks for BPEF and BPF, giving the company a competitive edge through vertical integration [3] - The combination of BPEF and BPF products will allow the company to meet diverse market demands, further solidifying its leading position in the BPEF market [3]

Group 1 - The PEEK concept sector is showing strength, with notable stock increases from companies such as Zhaomin Technology, Xingrui Technology, Xinhan New Materials, Zhongxin Fluorine Materials, Henghe Precision, and Kent Shares [1] - The stocks mentioned are leading in terms of percentage gains within the PEEK concept sector [1] - The report indicates a significant market movement in the PEEK sector as of February 6, with specific companies highlighted for their performance [1]

Core Viewpoint - Zhejiang Zhongxin Fluorine Materials Co., Ltd. has received approval from the China Securities Regulatory Commission for a simplified procedure to issue stocks to specific investors for the year 2025 [1][2]. Group 1 - The company has been granted registration approval for the stock issuance application [1]. - The issuance must be conducted strictly according to the submitted documents and issuance plan to the Shenzhen Stock Exchange [2]. - The company is required to complete the issuance payment within ten working days from the date of the approval [3]. Group 2 - The company must report any significant events to the Shenzhen Stock Exchange from the date of approval until the completion of the issuance [3]. - The board of directors will handle the stock issuance matters within the stipulated timeframe and fulfill information disclosure obligations [3]. - Contact information for the issuer and the sponsor institution (main underwriter) is provided for further inquiries [4].

Company Announcements - Tianqi Mould is planning a major asset restructuring and will be suspended from trading starting February 6 [1] - Jiangfeng Electronics intends to acquire control of Kaide Quartz for 591 million yuan, with trading resuming on February 6 [2][3] - Beikong Leisure's actual controller, Ma Xuejun, is under investigation by the China Securities Regulatory Commission for alleged market manipulation [4][5] Performance Highlights - In 2025, Yingjixin reported a total revenue of 1.611 billion yuan, a year-on-year increase of 12.65%, and a net profit of 177.44 million yuan, up 42.81% from the previous year [6] Capital Increase & Restructuring - Guoxuan High-Tech plans to raise no more than 5 billion yuan through a private placement to fund a 20GWh power battery project and other initiatives [7] - Zhongxin Fluorine Materials received approval from the CSRC for a simplified procedure to issue shares to specific investors in 2025 [7] Important Matters - Runze Technology is planning to issue convertible bonds to purchase assets and raise supporting funds, with trading suspended from February 6 [8] - ST Cube's stock price increased by 314.93% from January 20 to February 5, leading to a suspension for verification due to a significant deviation from its fundamentals [8] - Muyuan Foods reported a January sales revenue of 10.566 billion yuan from commodity pigs, a year-on-year decrease of 11.93% [8] Other Developments - GCL-Poly has not yet received any orders in the "space photovoltaic" sector, which remains in the exploratory stage [9] - Huizhou Energy achieved a power generation of 4.264 billion kWh in January, a year-on-year increase of 26.38% [10] - Taiji Industry's subsidiary is part of a consortium that has pre-qualified for a semiconductor project with a bid of 3.778 billion yuan [10][11]

Group 1 - Company Jianhui Information plans to acquire 38% equity in Boke Guoxin for RMB 73.71 million, increasing its stake from 32% to 70%, making Boke Guoxin a subsidiary [1] - Company Guangshengtang's innovative drug GST-HG141 for hepatitis B has completed the enrollment of 578 participants in its Phase III clinical trial [2] - Company Hongjing Optoelectronics is establishing a partnership with a target scale of RMB 290 million, contributing RMB 3 million as a limited partner [3] Group 2 - Company Hongchang Technology intends to acquire 21% equity in Liangzhi Joint, which will make it the controlling shareholder with a 51% stake [4] - Company Xiexin Integrated has not yet received any orders in the "space photovoltaic" sector, which remains in the exploratory phase [5] - Company Xianheng International plans to reduce its shareholding by up to 3%, amounting to a maximum of 12.28 million shares [6] Group 3 - Company Furuijia plans to reduce its repurchased shares by up to 2%, totaling 18.93 million shares [7] - Company Tianqimo is planning to issue shares and pay cash to acquire assets, leading to a temporary suspension of its stock [8] - Company Shuangqiang Technology's director plans to reduce his holdings by up to 0.32% [9] Group 4 - Company Bairun plans to adjust the conversion price of its bonds due to stock prices falling below 85% of the conversion price [11] - Company Dongnan Network has won an EPC project worth RMB 994 million [12] - Company Anhui Energy has appointed Xu Wengong as the new general manager following the resignation of Fang Shiqing [13] Group 5 - Company Lijun plans to invest up to USD 3 million to establish subsidiaries in Hong Kong and Peru [14] - Company Zhenghe Ecology has signed a strategic cooperation agreement with the government of Beijing's Miyun District [15] - Company First Venture has elected Guo Chuan as the chairman of its board [16] Group 6 - Company Changxin Bochuang's shareholder has terminated an agreement to transfer 14.5 million shares [17] - Company Hengrui Medicine's HR091506 tablet application has been accepted by the National Medical Products Administration [18] - Company Hengrui Medicine's SHR-1894 injection has received approval for clinical trials [20] Group 7 - Company Longshen Rongfa has obtained a medical device production license [21] - Company Western Securities reported that its new borrowings exceeded 20% of its net assets [22] - Company Rongfa Nuclear Power's subsidiary has won a project worth RMB 101 million [23] Group 8 - Company Taiji Industry's subsidiary has a pre-bid for the Huahong FAB9B project with a bid amount of RMB 3.778 billion [24] - Company Suzhou High-tech plans to increase its investment in a subsidiary by RMB 780 million through a debt-to-equity swap [26] - Company Electric Power Investment's vice president has resigned due to work changes [27] Group 9 - Company Hengwei Technology reported a 30.13% increase in net profit for 2025 [28] - Company Fangsheng Pharmaceutical's subsidiary has received a drug production license [29] - Company Pilin Bio's subsidiary has received a notice for clinical trial acceptance for a hemostatic drug [31] Group 10 - Company Zhongxin Fluorine Material has received approval for a stock issuance to specific investors [32] - Company Shanhe Intelligent expects a total transaction amount with related parties to be RMB 1.197 billion in 2026 [33] - Company Warner Pharmaceutical's partner has completed Phase I clinical trials for a new drug [34]

Core Viewpoint - Zhejiang Zhongxin Fluorine Materials Co., Ltd. has received approval from the China Securities Regulatory Commission (CSRC) for a simplified procedure to issue stocks to specific investors for the year 2025, indicating a strategic move to raise capital for future growth [1]. Group 1: Stock Performance - As of February 5, 2026, Zhongxin Fluorine Materials' stock closed at 22.24 yuan, down 1.85% from the previous trading day, with a total market capitalization of 7.238 billion yuan [1]. - The stock opened at 22.55 yuan, reached a high of 22.65 yuan, and a low of 22.16 yuan, with a trading volume of 1.04 million yuan and a turnover rate of 1.61% [1]. Group 2: Regulatory Approval - The company received the CSRC's approval on February 4, 2026, for its application to issue stocks to specific investors, as documented in the approval notice (Zheng Jian Xu Ke [2026] No. 199) [1]. - The company is required to strictly follow the submitted documents and issuance plan to the Shenzhen Stock Exchange and must complete the issuance payment within ten working days after the approval [1]. - In case of significant events, the company must promptly report to the Shenzhen Stock Exchange and handle matters according to regulations [1].

Core Viewpoint - The company, Zhongxin Fluorine Materials, has received approval from the China Securities Regulatory Commission for its application to issue stocks to specific investors [1] Group 1 - The approval was granted on February 4, 2026, indicating a significant step in the company's capital-raising efforts [1] - The stock issuance is targeted at specific investors, which may suggest a strategic approach to funding [1]

智通财经APP讯，中欣氟材(002915.SZ)公告，公司于2026年2月4日收到中国证券监督管理委员会出具的 《关于同意浙江中欣氟材股份有限公司向特定对象发行股票注册的批复》，同意公司向特定对象发行股 票的注册申请。 ...

证券代码：002915 证券简称：中欣氟材 公告编号：2026-004 浙江中欣氟材股份有限公司 关于2025年度以简易程序向特定对象发行股票申请获得 公司董事会将根据上述文件和相关法律法规的要求及公司股东会的授权，在 规定期限内办理本次向特定对象发行股票相关事宜，并及时履行信息披露义务。 敬请广大投资者注意投资风险。 本次以简易程序向特定对象发行股票的发行人和保荐机构（主承销商）的联 系方式如下： 一、发行人：浙江中欣氟材股份有限公司 联系部门：董事会办公室 中国证券监督管理委员会同意注册批复的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 浙江中欣氟材股份有限公司（以下简称"公司"）于 2026 年 2 月 4 日收到 中国证券监督管理委员会出具的《关于同意浙江中欣氟材股份有限公司向特定对 象发行股票注册的批复》（证监许可〔2026〕199 号），批复的主要内容如下： 一、同意你公司向特定对象发行股票的注册申请。 二、你公司本次发行应严格按照报送深圳证券交易所的申报文件和发行方案 实施。 三、你公司应当在本批复作出十个工作日内完成发行缴款。 四、自同 ...